Jaguar Health (JAGX) Gross Margin Growth (1y) (2016 - 2026)

Jaguar Health (JAGX) Gross Margin Growth (1y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Nanobiotix 1,774.59 Bn 1,774.53 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
3 BeOne Medicines 473.53 Bn 468.74 Bn 1.35 Bn 372.00
4 Vertex Pharmaceuticals 123.91 Bn 116.66 Bn 2.59 Bn -5.00
5 Regeneron Pharmaceuticals 71.79 Bn 63.04 Bn 3.31 Bn -165.00
6 Belite Bio 62.15 Bn 62.15 Bn - -
7 Argenx Se 54.75 Bn 49.57 Bn 1.41 Bn 236.00
8 Alnylam Pharmaceuticals 38.10 Bn 35.10 Bn 959.66 Mn -597.00
9 Revolution Medicines 36.11 Bn 36.11 Bn - -
10 Jaguar Health 509,443.80 -9.55 Mn 19.11 Mn 1,755.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,755.00
Dec 31, 2025 -5,213.00
Sep 30, 2025 15.00
Jun 30, 2025 -200.00
Mar 31, 2025 -497.00
Dec 31, 2024 1,400.00
Sep 30, 2024 87.00
Jun 30, 2024 300.00
Mar 31, 2024 74,838.00
Dec 31, 2023 151,701.00
Sep 30, 2023 129.00
Jun 30, 2023 -308.00
Mar 31, 2023 150,833.00
Dec 31, 2022 -152,433.00
Sep 30, 2022 8,076.00
Jun 30, 2022 15,959.00
Mar 31, 2022 -222,674.00
Dec 31, 2021 808.00
Sep 30, 2021 593,044.00
Jun 30, 2021 718,909.00